Related Experiment Video
Updated: Apr 21, 2026
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Validation of a proposed novel equation for estimating LDL cholesterol
Jeffrey W Meeusen1, Alan J Lueke1, Allan S Jaffe2
1Division of Clinical Core Laboratory Services, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;
Insights
A new method for estimating low-density lipoprotein cholesterol (LDL-C) shows minor improvements over the Friedewald equation, particularly for LDL-C <70 mg/dL. However, its clinical utility for cardiovascular event prevention remains uncertain.
Area of Science:
- Cardiology
- Biochemistry
- Clinical Chemistry
Background:
- Aggressive low-density lipoprotein cholesterol (LDL-C) lowering is crucial for cardiovascular event prevention.
- Existing LDL-C estimation methods, like the Friedewald equation, have limitations.
- A novel LDL-C estimation equation has been developed to address these limitations.
Purpose of the Study:
- To independently evaluate the performance of a novel LDL-C estimation method.
- To compare the novel method against the Friedewald equation and a gold standard reference method.
- To assess the clinical utility of the novel method for LDL-C <70 mg/dL.
Main Methods:
- Utilized a large, independent cohort of 23,055 patients.
- Employed LDL-C measurements via the gold standard β-quantification reference method.
- Compared estimations from the Friedewald and novel equations against measured LDL-C.
Main Results:
- Both Friedewald and novel methods showed significant deviations from measured LDL-C, especially when LDL-C was <70 mg/dL.
- The novel method slightly improved classification accuracy (78%) compared to Friedewald (77%).
- The novel method reclassified 8.7% of patients with LDL-C <70 mg/dL to >70 mg/dL, a larger shift than Friedewald.
Conclusions:
- The novel LDL-C estimation method offers some advantages over the Friedewald equation.
- Substantive improvements in patient outcomes from adopting the novel method in routine practice are not yet clear.
- Further validation is needed to determine if the novel method's benefits justify a change in clinical practice.
Background:
Aggressive LDL cholesterol (LDL-C)-lowering strategies are recommended for primary and secondary prevention of cardiovascular events. A newly derived equation for LDL-C estimation was recently published that addressed limitations in the commonly used Friedewald LDL-C calculation method. The novel method was reported to classify patients with superior concordance to measured LDL-C compared to the Friedewald method, particularly in patients with LDL-C <70 mg/dL.
Methods:
We evaluated the performance of the novel method within an independent cohort of 23 055 patients with LDL-C measured by the gold standard β-quantification reference method.
Results:
Overall Friedewald underestimated and the novel method overestimated measured LDL-C. Both estimations significantly deviated from the reference method when LDL-C was <70 mg/dL. Overall, the Friedewald and novel calculations correctly classified 77% and 78% of patients, respectively. The largest discrepancy in classification was observed in individuals with measured LDL-C <70 mg/dL. For this group the novel calculation would reclassify 8.7% of patients as >70 mg/dL compared to the Friedewald equation.
Conclusions:
We compared both novel and Friedewald estimated LDL-C against the LDL-C reference method; in contrast, the prior study relied on validation of a subset of samples by β-quantification to allow the use of the vertical autoprofile method for LDL-C measurement. We conclude that the novel method has some benefits but it is unclear whether improvements over the Friedewald calculation are substantive enough to justify making the change in routine clinical practice and to improve patient outcomes.
More Related Videos
Related Concept Videos
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
01:18Lipids: Dietary Sources and Requirements
01:29Cholesterol: Significance and Regulation
Considering cholesterol and...